Growth factor loaded-microparticles as a tool for cardiac repair

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Engineering

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Delivery of basic fibroblast growth factor with a pH-responsive, injectable hydrogel to improve angiogenesis in infarcted myocardium.

  2011cited by this paper
• Modulation of cardiac macrophages by phosphatidylserine-presenting liposomes improves infarct repair

  2011cited by this paper
• Acidic and basic fibroblast growth factors involved in cardiac angiogenesis following infarction.

  2011cited by this paper
• Differentiation of cardiosphere-derived cells into a mature cardiac lineage using biodegradable poly(N-isopropylacrylamide) hydrogels.

  2011cited by this paper
• Infarct stabilization and cardiac repair with a VEGF-conjugated, injectable hydrogel.

  2011cited by this paper
• Effects of protein dose and delivery system on BMP-mediated bone regeneration.

  2011cited by this paper
• Temperature-induced gel formation of core/shell nanoparticles for the regeneration of ischemic heart.

  2010cited by this paper
• Sustained release of VEGF through PLGA microparticles improves vasculogenesis and tissue remodeling in an acute myocardial ischemia-reperfusion model.

  2010influential reference
• Sustained VEGF delivery via PLGA nanoparticles promotes vascular growth.

  2010cited by this paper
• Vascular endothelial growth factors and vascular permeability

  2010cited by this paper
• Improving regenerating potential of the heart after myocardial infarction: factor-based approach.

  2010cited by this paper
• Combination of Injectable Multiple Growth Factor-Releasing Scaffolds and Cell Therapy as an Advanced Modality to Enhance Tissue Neovascularization

  2010cited by this paper
• Improved myocardial performance in infarcted rat heart by co-injection of basic fibroblast growth factor with temperature-responsive chitosan hydrogel.

  2010cited by this paper
• The delivery of superoxide dismutase encapsulated in polyketal microparticles to rat myocardium and protection from myocardial ischemia-reperfusion injury.

  2010cited by this paper
• Targeting VEGF‐encapsulated immunoliposomes to MI heart improves vascularity and cardiac function

  2009cited by this paper
• Ischemic heart diseases: current treatments and future.

  2009cited by this paper
• Modification of Biodegradable Poly(Malate) and Poly(Lactic-co-Glycolic Acid) Microparticles with Low Molecular Polyethylene Glycol

  2009cited by this paper
• Development of highly porous large PLGA microparticles for pulmonary drug delivery.

  2009cited by this paper
• Breaking the silence: stimulating proliferation of adult cardiomyocytes.

  2009cited by this paper
• Effective GDNF brain delivery using microspheres--a promising strategy for Parkinson's disease.

  2009cited by this paper
• Sustained delivery of FGF-1 increases vascular density in comparison to bolus administration.

  2009cited by this paper
• Neuregulin1/ErbB4 signaling induces cardiomyocyte proliferation and repair of heart injury.

  2009cited by this paper
• Stem Cell Therapy with Overexpressed VEGF and PDGF Genes Improves Cardiac Function in a Rat Infarct Model

  2009cited by this paper
• The dosage dependence of VEGF stimulation on scaffold neovascularisation.

  2008cited by this paper
• Sustained release of a p38 inhibitor from non-inflammatory microspheres inhibits cardiac dysfunction.

  2008cited by this paper
• Cardiomyocyte death and renewal in the normal and diseased heart.

  2008cited by this paper
• IGF-1–Overexpressing Mesenchymal Stem Cells Accelerate Bone Marrow Stem Cell Mobilization via Paracrine Activation of SDF-1α/CXCR4 Signaling to Promote Myocardial Repair

  2008cited by this paper
• Growth factors and cell therapy in myocardial regeneration.

  2008cited by this paper
• Paracrine Mechanisms in Adult Stem Cell Signaling and Therapy

  2008cited by this paper
• Sustained release of bioactive glycosylated glial cell-line derived neurotrophic factor from biodegradable polymeric microspheres.

  2008influential reference
• VEGF-A and the induction of pathological angiogenesis.

  2007cited by this paper
• Clinical and angiographic predictors of outcome after primary angioplasty

  2007cited by this paper
• Periostin induces proliferation of differentiated cardiomyocytes and promotes cardiac repair

  2007cited by this paper
• Evidence from a genetic fate-mapping study that stem cells refresh adult mammalian cardiomyocytes after injury

  2007cited by this paper
• Cardiovascular gene therapy: current status and therapeutic potential

  2007cited by this paper
• Identification of Myocardial and Vascular Precursor Cells in Human and Mouse Epicardium

  2007cited by this paper
• Adolescent Feline Heart Contains a Population of Small, Proliferative Ventricular Myocytes With Immature Physiological Properties

  2007cited by this paper
• Targeted delivery of antibody conjugated liposomal drug carriers to rat myocardial infarction

  2007cited by this paper
• Angiogenic effects of sequential release of VEGF-A165 and PDGF-BB with alginate hydrogels after myocardial infarction.

  2007cited by this paper
• Acute coronary syndromes: unstable angina/non-ST elevation myocardial infarction.

  2007cited by this paper
• Angiogenic gene therapy in patients with nonrevascularizable ischemic heart disease: a phase 2 randomized, controlled trial of AdVEGF121 (AdVEGF121) versus maximum medical treatment

  2006cited by this paper
• FGF1/p38 MAP kinase inhibitor therapy induces cardiomyocyte mitosis, reduces scarring, and rescues function after myocardial infarction

  2006cited by this paper
• Cytokines produced by bone marrow cells can contribute to functional improvement of the infarcted heart by protecting cardiomyocytes from ischemic injury.

  2006cited by this paper
• Phagocytosis of PLGA Microparticles in Rat Peritoneal Exudate Cells: A Time-Dependent Study

  2006influential reference
• Temporally regulated delivery of VEGF in vitro and in vivo.

  2006cited by this paper
• Neuregulin-1/erbB-activation improves cardiac function and survival in models of ischemic, dilated, and viral cardiomyopathy.

  2006cited by this paper
• Adeno-Associated Virus-Mediated Transduction of VEGF165 Improves Cardiac Tissue Viability and Functional Recovery After Permanent Coronary Occlusion in Conscious Dogs

  2006cited by this paper
• Investigating the effect of VEGF glycosylation on glycosaminoglycan binding and protein unfolding.

  2006cited by this paper
• Cardioprotective c-kit+ cells are from the bone marrow and regulate the myocardial balance of angiogenic cytokines.

  2006cited by this paper
• Administration of Control-Released Hepatocyte Growth Factor Enhances the Efficacy of Skeletal Myoblast Transplantation in Rat Infarcted Hearts by Greatly Increasing Both Quantity and Quality of the Graft

  2005cited by this paper
• Biodegradable poly(lactic-co-glycolic acid) microparticles for injectable delivery of vaccine antigens.

  2005cited by this paper
• Safety and efficacy of subcutaneous-only granulocyte-macrophage colony-stimulating factor for collateral growth promotion in patients with coronary artery disease.

  2005cited by this paper
• Direct intramyocardial plasmid vascular endothelial growth factor-A165 gene therapy in patients with stable severe angina pectoris A randomized double-blind placebo-controlled study: the Euroinject One trial.

  2005cited by this paper
• p38 MAP kinase inhibition enables proliferation of adult mammalian cardiomyocytes.

  2005cited by this paper
• Sustained delivery of vascular endothelial growth factor with alginate beads.

  2004cited by this paper
• Vascular endothelial growth factor: basic science and clinical progress.

  2004cited by this paper
• Loading of plasmid DNA into PLGA microparticles using TROMS (Total Recirculation One-Machine System): evaluation of its integrity and controlled release properties.

  2003cited by this paper
• The VIVA Trial Vascular Endothelial Growth Factor in Ischemia for Vascular Angiogenesis

  2003cited by this paper
• Localized arteriole formation directly adjacent to the site of VEGF-induced angiogenesis in muscle.

  2003cited by this paper
• Angiogenesis in health and disease

  2003cited by this paper
• Ventricular remodeling after infarction and the extracellular collagen matrix: when is enough enough?

  2003influential reference
• The inflammatory response in myocardial infarction.

  2002cited by this paper
• Cardiac cytokine expression is upregulated in the acute phase after myocardial infarction. Experimental studies in rats.

  2002cited by this paper
• Conditional switching of VEGF provides new insights into adult neovascularization and pro‐angiogenic therapy

  2002cited by this paper
• Residual polyvinyl alcohol associated with poly (D,L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake.

  2002cited by this paper
• Angioplasty Versus Bypass Surgery for Coronary Artery Disease

  2002cited by this paper
• Angiogenic Gene Therapy (AGENT) Trial in Patients With Stable Angina Pectoris

  2002cited by this paper
• Pharmacological Treatment of Coronary Artery Disease With Recombinant Fibroblast Growth Factor-2: Double-Blind, Randomized, Controlled Clinical Trial

  2002cited by this paper
• Therapeutic angiogenesis for ischemic cardiovascular disease.

  2001cited by this paper
• VEGF gene delivery to myocardium: deleterious effects of unregulated expression.

  2000cited by this paper
• The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices.

  2000cited by this paper
• Infections, inflammation, and the risk of coronary heart disease.

  2000cited by this paper
• Development and in vitro characterization of vascular endothelial growth factor (VEGF)-loaded poly(DL-lactic-co-glycolic acid)/poly(ethylene glycol) microspheres using a solid encapsulation/single emulsion/solvent extraction technique.

  2000cited by this paper
• VEGF gene therapy: stimulating angiogenesis or angioma-genesis?

  2000cited by this paper
• Vascular permeability factor/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis.

  1999cited by this paper
• Hormones and hemodynamics in heart failure.

  1999cited by this paper
• Why Does PEG 400 Co-Encapsulation Improve NGF Stability and Release from PLGA Biodegradable Microspheres?

  1999cited by this paper
• Delivering neuroactive molecules from biodegradable microspheres for application in central nervous system disorders.

  1999cited by this paper
• Protein delivery from poly(lactic-co-glycolic acid) biodegradable microspheres: release kinetics and stability issues.

  1998cited by this paper
• Cytokine gene expression after myocardial infarction in rat hearts: possible implication in left ventricular remodeling.

  1998cited by this paper
• Improving protein therapeutics with sustained-release formulations

  1998cited by this paper
• The delivery of angiogenic factors to the heart by microsphere therapy

  1998cited by this paper
• Influence of experimental parameters on the characteristics of poly(lactic acid) nanoparticles prepared by a double emulsion method.

  1998cited by this paper
• Vascular Endothelial Growth Factor Induces Heparin-binding Epidermal Growth Factor-like Growth Factor in Vascular Endothelial Cells*

  1998cited by this paper
• Induction of neoangiogenesis in ischemic myocardium by human growth factors: first clinical results of a new treatment of coronary heart disease.

  1998cited by this paper
• Biodegradation and biocompatibility of PLA and PLGA microspheres.

  1997cited by this paper
• Angiogenesis induced by acidic fibroblast growth factor as an alternative method of revascularization for chronic myocardial ischemia.

  1996cited by this paper
• Purification and Characterization of a Naturally Occurring Vascular Endothelial Growth Factor · Placenta Growth Factor Heterodimer (*)

  1995cited by this paper
• Intracoronary injection of basic fibroblast growth factor enhances angiogenesis in infarcted swine myocardium.

  1993cited by this paper
• Endothelial modulation of porcine coronary microcirculation perfused via immature collaterals.

  1992cited by this paper
• Controlled Delivery Systems for Proteins Based on Poly(Lactic/Glycolic Acid) Microspheres

  1991cited by this paper
• PLATELETS, ENDOTHELIUM AND VASOSPASM

  1985cited by this paper
• The FASEB Journal • FJ Express Full-Length Article Microenvironmental VEGF distribution is critical for stable and functional vessel growth in ischemia

  year unknowncited by this paper

• No citing papers are available for this paper.